• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Friday, October 25, 2019

    Offline Date

    Sunday, September 25, 2022

    ACPE Expiration Date

    Sunday, September 25, 2022

    Target Audience

    Pharmacist, Nurse

    Cost

    $4.00

    • Overview

      Acute venous thromboembolism (VTE) typically requires treatment with anticoagulants for at least 3 months, and for longer periods in more complicated cases. During this treatment interval it is not uncommon for patients to also require surgery or invasive medical procedures unrelated to their VTE, raising questions as to how best to manage anticoagulants in the periprocedural period. While high-quality studies have identified best practices for anticoagulation management among patients with atrial fibrillation who require invasive procedures, to date no prospective, randomized, controlled studies have been performed to guide decision-making for patients receiving anticoagulation therapy for VTE. This program uses an expert panel discussion to evaluate the findings of a recent systematic review regarding the use of periprocedural “bridging” with parenteral anticoagulants among patients utilizing vitamin K antagonists for the treatment of VTE.

      Handouts

      • Slide Document :   Periprocedural Bridging in Patients With VTE handouts.pdf

      Financial Support By

      PharmCon, Inc and the Anticoagulation Forum
    • Pharmacist

      Identify patient populations in whom the risk of bridging likely outweighs the clinical benefits
      Identify appropriate possible strategies to implement shared decision-making involving patients, proceduralists, and other care providers
      Describe the current state of medical evidence regarding bridging for VTE Patients utilizing vitamin K antagonists who require invasive medical procedures

      Nurse

      Identify appropriate possible strategies to implement shared decision-making involving patients, proceduralists, and other care providers
      Describe the current state of medical evidence regarding bridging for VTE Patients utilizing vitamin K antagonists who require invasive medical procedures
      Identify patient populations in whom the risk of bridging likely outweighs the clinical benefits
    • Activity Type

      Knowledge

      CE Broker

      20-737618

      Universal Activity Number

      Pharmacist 0798-0000-19-171-H01-P
      Nurse 0798-0000-19-171-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).